Search - tctmd.com

Displaying 561 - 580 of 923

Sort: Relevancy | Date

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Gender Differences in the Safety of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Presenter: Abhishek Sharma

June 14, 2019

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

L.A. McKeown

May 07, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

Presentation ECHO/IMAGING 2019

Hypertrophic Cardiomypathy A Comprehensive Assessment - The Role of Imaging Focus on Echo

Presenter: Kyle W. Klarich

March 23, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 2: inflammatory Cardiomyopathy

Presenter: John P. Bois, Panithaya Chareonthaitawee

March 23, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

Presenter: John P. Bois

March 23, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

Presenter: John P. Bois

March 23, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

Advertisement

Hemodynamics: The Forgotten Branch of Cardiology

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Gender Differences in the Safety of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Cancer Survivors With Heart Failure Respond Well to CRT

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Hypertrophic Cardiomypathy A Comprehensive Assessment - The Role of Imaging Focus on Echo

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 2: inflammatory Cardiomyopathy

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content